What to Expect When Medtronic (MDT) Reports Earnings Tuesday Morning

NEW YORK (TheStreet) -- Shares of Medtronic PLC  (MDT) were up 0.24% to $76.50 in late morning trading Monday, one day ahead of the medical supplies company's fourth quarter earnings results, expected to be released before the market opens Tuesday.

TheStreet's Jim Cramer, Portfolio Manager of the Action Alerts PLUS Charitable Trust Portfolio said on CNBC's Mad Money show Friday that he expects a surprise to the upside for Medtronic.

Analysts are expecting Medtronic to earn $1.11 per share on revenue of $7.16 billion for the quarter, according to Thomson Reuters data.

In the same period of last year, the company earned $1.15 per share on revenue of $4.57 billion.

Ireland-based Medtronic is a medical technology, services and solutions company that offers its products to hospitals, physicians, clinicians and patients in more than 160 countries.

The company's portfolio includes surgical, respiratory and monitoring, and vascular therapies solutions along with a line of patient care products to alleviate pain, restore health and extend life for people.

Separately, TheStreet Ratings team rates MEDTRONIC PLC as a Buy with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:

"We rate MEDTRONIC PLC (MDT) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, solid stock price performance, good cash flow from operations and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated."

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning